Follow Us:
What's New with the Flu
Infectious Diseases
Curriculum:
What's New with the Flu
What's New with the Flu
Credits:
0.5 AMA PRA Category 1 Credit(s) ™ 0.5 AAPA Category 1 Credit(s)
0.5 AMA PRA Category 1 Credit(s) ™ 0.5 AAPA Category 1 Credit(s)
Launch Date:
March 07, 2019
March 07, 2019
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Primary care physicians, emergency medicine providers
Relevant Terms:
Influenza, Treating Influenza, Influenza Vaccination
Paul Auwaerter, MD, MBA
Paul Auwaerter, MD, MBA
Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Bio
Dr. Paul G. Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.
He serves as the Executive Director of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center producing the Johns Hopkins ABX (Antibiotic), JH HIV, JH Osler, JH Psychiatry and JH Diabetes Guides. As managing editor for the ABX Guide for over 14 years, this guide has grown to be a standard reference for ID-related clinical decision support and rationale antimicrobial management. Dr. Auwaerter’s research and clinical interests include improving the diagnosis and care for patients with Lyme disease as well as interests in surgical infections, Epstein-Barr virus, and antibiotic resistance. This year he is serving as Immediate Past-President of the Infectious Diseases Society of America, the largest professional society worldwide related to infectious diseases.
Jean David Dumornay, MD, MBA
Jean David Dumornay, MD, MBA
Family Medicine
Penn Medicine Urgent Care Network
Lancaster General Health
Lancaster, Pennsylvania
Bio
Dr. Jean David Dumornay is passionate about continuous staff development through advanced training and mentoring. He is a front-line soldier in the flu epidemic.
Dr. Dumornay graduated from the Universite d’Etat d’Haiti, Faculte de Medecine et de Pharmacie, Port-au-Prince, Haiti in 1995. He then completed a residency in family medicine at the Penn Medicine Lancaster General Family and Community Medicine residency program, Lancaster PA, 2006 – 2009 and his Physician Executive MBA at Auburn University, Auburn, Alabama, in May 2018.
Dr. Dumornay has 23 years of combined emergency department, urgent care, international and tropical medicine experience. Additionally, he has over 12 years in an international medical philanthropic setting with extensive experience in philanthropic medical team leadership and management in a challenging environment.
Thomas C. Raff, MD
Thomas C. Raff, MD
Family Medicine
Penn Medicine Urgent Care Network
Lancaster General Health
Lancaster, Pennsylvania
Bio
Dr. Thomas Raff is currently the Associate Director of the Urgent Care Network at Lancaster General Hospital, University of Pennsylvania. He graduated from the Medical College of Virginia at Virginia Commonwealth University in 1989 and completed his residency in family medicine at the Lancaster General Hospital from 1990-1993. Dr. Raff subsequently worked in private practice for 7 years and engaged in academic practice for 20 years at the Reading Hospital and Medical Center, where he specialized in family medicine, obstetrics and emergency room care.
| 1. | Explain and apply CDC and other guidelines for vaccination and initiating antiviral treatment in specific patient populations | 2. | Assess profiles of current and emerging antiviral therapies used to treat influenza |
| 3. | Demonstrate effective communication techniques to address perceptions of symptom severity, vaccination measures, and therapeutic safety and efficacy |
| 1. | Explain and apply CDC and other guidelines for vaccination and initiating antiviral treatment in specific patient populations |
| 2. | Assess profiles of current and emerging antiviral therapies used to treat influenza |
| 3. | Demonstrate effective communication techniques to address perceptions of symptom severity, vaccination measures, and therapeutic safety and efficacy |
This activity is supported by an educational grant from Genentech.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Paul G. Auwaerter, MD, MBA: Consulting fees for BioMeriux
John David Dumornay, MD, MBA: None
Thomas C. Raff, MD: None
The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
The PIM planners and managers have nothing to disclose.
The following DKB planners and managers Dean Beals, Stan Pogroszewski, Rachel Deerr, and Cade Schreger hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation and Request for Credit
There are no fees for participation in this CME activity. To receive credit, participants must 1) read the learning objectives and disclosure statements, 2) complete the educational activity and 3) complete the post-test and activity evaluation form, including the certificate information section. Physicians and social workers must attest to the amount of time they spent on the activity.
Course Viewing Requirements
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
